The UFOVAX leadership team has experience in the board of directors at Molecular Targeting Technology, Inc., as the president and CEO at Uvax Bio, and as a director at Wilmington PharmaTech Company LLC. They also have a managing director for the Feixiang Group's M&A, technology development, and pharmaceutical division. The team is educated from Princeton University in organic chemistry.